SCHEMBL2212307

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL7784021	0.88	NR5A1 (0.52)	LTA4HMAPTHTR1AHTR1BPDK2
	SCHEMBL8454472	0.86	NR5A1 (0.55)	LTA4HMAPTHTR1AHTR1B
	SCHEMBL17432926	0.86	MRGPRX4 (0.47)	LTA4HCA12CA1CA2CA7
	SCHEMBL23473367	0.84	PTGS1 (0.45)	LTA4HCA12CA1CA2CA7
	SCHEMBL1547853	0.83	NQO1 (0.56)	LTA4HMAOBAOC3MAPTKMT2A
	SCHEMBL17534283	0.82	LTA4H (0.55)	LTA4HCA12CA1CA2CA7
	SCHEMBL26426449	0.82	CA12 (0.43)	LTA4HCA12CA1CA2CA7
	SCHEMBL24429662	0.82	MAPT (0.55)	LTA4HCA12CA1CA2CA7
	SCHEMBL17433278	0.82	GPR84 (0.50)	LTA4HCA12CA1CA2CA7
	SCHEMBL19059333	0.82	CA12 (0.45)	LTA4HCA12CA1CA2CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.